Psychological impact and quality of life in pediatric patients with chronic skin disorders: a systematic review (2010–2025) - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Effects of Chronic Skin Conditions on Psychological Well-Being and Quality of Life in Pediatric Patients: A Systematic Review (2010–2025)

  • By

  • Abdulaziz Fahd AlKaabba

  • Shahd Muhammed Aldosari

  • Taif Abdullah Alwadai

  • Aldana Abdulrahaman Alodayani

  • Duna Saad Alhumaidan

  • Wajed Shuliweeh Alenezi

  • Renad Sami Almuharib

  • Renad Abdullah Almosa

  • July 3, 2026

Share

  • 1

    Chronic skin disorders in pediatric patients significantly impact psychological well-being and health-related quality of life.

  • 2

    A systematic review identified 41 studies, revealing high rates of anxiety, depression, and emotional distress among affected children.

  • 3

    Severe atopic dermatitis was linked to nearly double the risk of depressive symptoms in longitudinal studies.

  • 4

    Caregiver burden was documented in 19 studies, highlighting the psychological impact on families managing chronic skin conditions.

  • 5

    The findings emphasize the need for routine psychosocial assessments and family-centered care in pediatric dermatology.

Original Source(s)

Psychological impact and quality of life in pediatric patients with chronic skin disorders: a systematic review (2010–2025)

  • by Abdulaziz Fahd AlKaabba, Shahd Muhammed Aldosari, Taif Abdullah Alwadai, Aldana Abdulrahaman Alodayani, Duna Saad Alhumaidan, Wajed Shuliweeh Alenezi, Renad Sami Almuharib, Renad Abdullah Almosa

  • July 3, 2026

Related Content

Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival

Spondyloarthritis function varies by sex

Women had greater functional deterioration over 17 years, while permanent work disability did not differ significantly between sexes.

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis